Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_assertion type Assertion NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_head.
- NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_assertion wasGeneratedBy ECO_0000203 NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_provenance.
- NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_assertion wasDerivedFrom befree-20140225 NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_provenance.
- NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_assertion SIO_000772 23588304 NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_provenance.
- NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_assertion evidence source_evidence_literature NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_provenance.
- NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_assertion description "[A predictive model combining variants in TPMT, ABCC3, and COMT with clinical variables (patient age, vincristine treatment, germ-cell tumor, and cranial irradiation) significantly improved the prediction of hearing-loss development as compared with using clinical risk factors alone (area under the curve (AUC) 0.786 vs. 0.708, P = 0.00048).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802803.RAYd-m-MTe_VFiv4yln1Rsjq_-IXS2TVVbVjtFJRbvAYw130_provenance.